XML 11 R4.htm IDEA: XBRL DOCUMENT v3.25.3
UNAUDITED CONDENSED STATEMENTS OF OPERATIONS - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2025
Professional fees and other expenses $ (338,040) $ (566,816)
Net loss from operations (338,040) (566,816)
Change in fair value of public and private warrant liabilities (1,524,900) (5,292,300)
Allocated expense for warrant issuance cost (1,062) (103,033)
Other income - interest income 3,707,618 6,013,852
Net income $ 1,843,616 $ 51,703
Class A Redeemable Ordinary Shares    
Net loss per ordinary share:    
Basic weighted average shares outstanding 35,880,000 19,582,857
Diluted weighted average shares outstanding 35,880,000 19,582,857
Basic net loss per share $ (0.65) $ (1.1)
Diluted net loss per share $ (0.65) $ (1.08)
Class A Non-Redeemable Ordinary Shares    
Net loss per ordinary share:    
Basic weighted average shares outstanding 225,000 122,802
Diluted weighted average shares outstanding 225,000 122,802
Basic net loss per share $ (0.65) $ (1.1)
Diluted net loss per share $ (0.65) $ (1.08)
Class B Ordinary Shares    
Net loss per ordinary share:    
Basic weighted average shares outstanding [1],[2] 8,970,000 8,438,571
Diluted weighted average shares outstanding [1],[2] 8,970,000 8,970,000
Basic net loss per share $ (0.65) [3],[4] $ (1.1)
Diluted net loss per share $ (0.65) [3],[4] $ (1.08)
[1] On June 30, 2023, the Sponsor paid $25,000 to cover certain of the Company’s offering costs in consideration of 11,500,000 Founder Shares. On February 3, 2025, the Sponsor surrendered for no consideration 4,025,000 Founder Shares. On May 1, 2025, the Company effected a stock dividend with respect to its Class B ordinary shares of 1,495,000 shares thereof, resulting in an aggregate of 8,970,000 outstanding shares of Class B ordinary shares.
[2] Until the completion of the IPO on May 5, 2025, an aggregate of up to 1,170,000 Class B ordinary shares, $0.0001 par value, were subject to forfeiture if the over-allotment option was not exercised in full or in part by the underwriters. On May 5, 2025, the Company consummated its Initial Public Offering and sold 35.88 million Units, which includes the full exercise of the underwriter's over-allotment option, hence the 1,170,000 Class B ordinary shares are no longer subject to forfeiture and excluded from diluted shares outstanding.
[3] On June 30, 2023, the Sponsor paid $25,000 to cover certain of the Company’s offering costs in consideration of 11,500,000 Founder Shares. On February 3, 2025, the Sponsor surrendered for no consideration 4,025,000 Founder Shares. On May 1, 2025, the Company effected a stock dividend with respect to its Class B ordinary shares of 1,495,000 shares thereof, resulting in an aggregate of 8,970,000 outstanding shares of Class B ordinary shares.
[4] Until the completion of the IPO on May 5, 2025, an aggregate of up to 1,170,000 Class B ordinary shares, $0.0001 par value, were subject to forfeiture if the over-allotment option was not exercised in full or in part by the underwriters. On May 5, 2025, the Company consummated its Initial Public Offering and sold 35.88 million Units, which includes the full exercise of the underwriter's over-allotment option, hence the 1,170,000 Class B ordinary shares are no longer subject to forfeiture and excluded from diluted shares outstanding.